Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ZymoGenetics Axes 52 Jobs, Quits Discovery of Immunology Drugs, to Conserve Cash
Xconomy
Friday, December 4, 2009 - 8:51am
tags:
layoffs, ZymoGenetics
Can Novartis Win Race to Launch First Oral Drug for MS?
BNET Pharma
Friday, December 4, 2009 - 8:36am
tags:
MS, multiple sclerosis, Novartis, Merck KGaA
Glaxo's swine flu shot may give kids fever
Yahoo/AP
Friday, December 4, 2009 - 8:33am
tags:
GSK, swine flu, vaccines
Knives Drawn Over the 'Botax'
WSJ Online
Friday, December 4, 2009 - 7:22am
tags:
Botox, Allergan, healthcare reform, Botax bill, healthcare bill
FDA Issues Serious Warning For Abbott’s Depakote
Pharmalot
Friday, December 4, 2009 - 7:20am
tags:
Abbott Laboratories, warning, Depakote, FDA
AstraZeneca gets FDA OK for Seroquel XR add-on
Marketwatch
Friday, December 4, 2009 - 7:17am
tags:
Seroquel XR, AstraZeneca, major depressive disorder
Genzyme: Positive Development on the Lumizyme Front
Seeking Alpha
Thursday, December 3, 2009 - 7:30pm
tags:
Lumizyme, Genzyme, Pompe disease
Facet Biotech Advises Stockholders to Take No Action in Response to Revised Biogen Idec Tender Offer
Yahoo
Thursday, December 3, 2009 - 7:28pm
tags:
Biogen Idec, Facet Biotech, M&A
No Free Lunch for Doctors, Brought to You By Jersey’s AG
WSJ Online
Thursday, December 3, 2009 - 7:27pm
tags:
New Jersey, physicians
Biogen raises Facet offer to $17.50 per share
Yahoo/AP
Thursday, December 3, 2009 - 5:40pm
tags:
Facet Biotech, Biogen Idec, M&A
Should Amgen Buy Human Genome Sciences?
Forbes
Thursday, December 3, 2009 - 5:39pm
tags:
Human Genome Sciences, Amgen, M&A
Cubist Pharma says reviewers found more deaths in patients taking its drug; Dyax stock skids
Yahoo/AP
Thursday, December 3, 2009 - 5:38pm
tags:
Dyax, Cubist Pharmaceuticals
Pharma Spending On Detailing Is Up: CBO
Pharmalot
Thursday, December 3, 2009 - 3:17pm
tags:
detailing, pharm reps, drug reps, drug marketing
No Holiday For Biopharma P & A
CNBC
Thursday, December 3, 2009 - 3:10pm
tags:
partnerships, M&A, Pfizer, Protalix BioTherapeutics, Targacept, AstraZeneca, Merck, Amgen, GSK, Human Genome Sciences
Novartis buy seen likely after Alcon shares gain
Reuters
Thursday, December 3, 2009 - 11:22am
tags:
Novartis, M&A, Alcon, Nestle
Drug reps or DTC? Congress checks it out
Fierce Pharma
Thursday, December 3, 2009 - 11:20am
tags:
congress, DTC, drug reps
Consumer safety group seeks FDA ban of weight loss pill Meridia, citing heart attack risks
Yahoo/AP
Thursday, December 3, 2009 - 11:19am
tags:
Meridia, weight loss, side effects, Abbott Laboratories, Public Citizen
Behind the Business: 3 Questions for Vical
Motley Fool
Thursday, December 3, 2009 - 11:18am
tags:
Vical
Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline
Yahoo
Thursday, December 3, 2009 - 9:59am
tags:
pipelines, Isis Pharmaceuticals
Drug stocks gain; Endo shares retreat
Marketwatch
Thursday, December 3, 2009 - 9:58am
tags:
Endo, drug stocks, Aveed, testosterone

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.